KIBindingProject reference: 299136
Funded under :
Improving the selectivity of kinase inhibitors: Characterizing binding mechanisms of inhibitors targeting inactive states and allosteric sites
Total cost:EUR 168 896,4
EU contribution:EUR 168 896,4
Coordinated in:United Kingdom
Topic(s):FP7-PEOPLE-2011-IEF - Marie-Curie Action: "Intra-European fellowships for career development"
Call for proposal:FP7-PEOPLE-2011-IEFSee other projects for this call
Funding scheme:MC-IEF - Intra-European Fellowships (IEF)
Kinase proteins are key to signaling in eukaryotic cells, so it is not surprising that their dysfunction has been implicated in human diseases such as cancer and inflammatory disorders. As a result, kinases have become important targets for drug discovery. The majority of kinase inhibitors bind to the ATP-binding site, which is highly conserved among the different kinases. In order to increase inhibitor selectivity toward a desired target kinase, the focus has turned to developing inhibitors which bind to inactive conformations or allosteric sites.
The techniques frequently used to study inhibitor binding such as X-ray crystallography and docking are limited because they only sample a single structure. In reality, a protein is characterized by an ensemble of structures. Free energy calculations can sample many different conformations and provide a clear picture of the mechanisms of inhibitor binding. Since straightforward molecular dynamics simulations suffer from a time scale problem we use a novel computational technique, metadynamics, to enhance sampling. Using metadynamics calculations we propose to investigate the binding mechanisms of inhibitors which target the inactive conformation and allosteric sites.
We focus on two proteins which are targets for cancer therapy: p38 mitogen-activated protein kinase and Abl.
EU contribution: EUR 168 896,4
WC1E 6BT LONDON
Tel.: +44 20 3108 3020
Fax: +44 20 7813 2849
E-28029 Madrid Madrid
Tel.: +34 917328000